Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation

American Journal of the Medical Sciences

Volumn 333, Issue 2, 2007, Pages 67-73

  Schauer, Daniel P ^a   Johnston, Joseph A ^a,b   Moomaw, Charles J ^a   Wess, Mark ^a   Eckman, Mark H ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b US Outcomes Research   (United States)

Author keywords

Atrial fibrillation; Racial disparities; Warfarin

Indexed keywords

WARFARIN;

AFRICAN AMERICAN; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; EUROPEAN AMERICAN; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAID; MULTIVARIATE ANALYSIS; PRESCRIPTION; RACE DIFFERENCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; UNITED STATES; WARFARIN;

EID: 33847050210     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200702000-00001     Document Type: Article

References (44)

1. Smedley BD, Stith AY, Nelson AR, editors. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Institute of Medicine. Washington, D.C.: National Academies Press; 2002.
2. Canto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med 2000; 342:1094-100.
3. Oddone EZ, Horner RD, Johnston DC, et al. Carotid endarterectomy and race: do clinical indications and patient preferences account for differences? Stroke 2002;33:2936-43.
4. Gurwitz JH, Goldberg RJ, Malmgren JA, et al. Hospital transfer of patients with acute myocardial infarction: the effects of age, race, and insurance type. Am J Med 2002;112:528-34.
5. Ford ES, Cooper RS. Racial/ethnic differences in health care utilization of cardiovascular procedures: a review of the evidence. Health Serv Res 1995;30:237-52
6. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353:671-82.
7. Schneider AT, Kissela B, Woo D, et al. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke 2004;35:1552-6.
8. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004;35:426-31.
9. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary firstever and total incidence rates of stroke among blacks. Stroke 1998;29:415-21.
10. Woo D, Gebel J, Miller R, et al. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke 1999;30:2517-22.
11. Gillum RF. Stroke mortality in blacks. Disturbing trends. Stroke 1999;30:1711-5.
12. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259-68.
13. Bravata DM, Wells CK, Gulanski B, et al. Racial disparities in stroke risk factors: the impact of socioeconomic status. Stroke 2005;36:1507-11.
14. Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 2003;34:2693-7.
15. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992;327:1406-12.
16. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991;84:527-39.
17. Connolly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18:349-55.
18. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;1:175-9.
19. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med. 1990;23:1505-11.
20. Scott PA, Pancioli AM, Davis LA, et al. Prevalence of atrial fibrillation and antithrombotic prophylaxis in emergency department patients. Stroke 2002;33:2664-9.
21. Johnston JA, Cluxton RJ Jr, Heaton PC, et al. Predictors of warfarin use among Ohio Medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med 2003;163:1705-10.
22. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke 2000;31:822-7.
23. Brophy MT, Snyder KE, Gaehde S, et al. Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc 2004;52:1151-6.
24. Man-Son-Hing M, Nichol G, Lau A, et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999;159:677-85.
25. Koroukian SM, Cooper GS, Rimm AA. Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population. Health Serv Res 2003;38:947-60.
26. Shireman TI, Olson BM, Dewan NA. Patterns of antidepressant use among children and adolescents. Psychiatr Serv 2002;53:1444-50.
27. Landefeld CS, Cook EF, Flatley M, et al. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82:703-13.
28. Lakshminarayan K, Solid CA, Collins AJ, et al. Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002). Stroke 2006;37:1969-74.
29. Trivedi AN, Zaslavsky AM, Schneider EC, et al. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med 2005;353:692-700.
30. Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998;97:1231-3.
31. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-34.
32. Fang MC, Stafford RS, Ruskin JN, et al. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 2004;164:55-60.
33. Kaiser Family Foundation: State Health Facts, http://www. Statehealthfacts.kff.org, accessed January 4, 2007.
34. Walkup JT, Boyer CA, Kellermann SL. Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health 2000;27:129-39.
35. Lurie N, Popkin M, Dysken M, et al. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry 1992;43:69-71.
36. Steinwachs DM, Stuart ME, Scholle S, et al. A comparison of ambulatory Medicaid claims to medical records: a reliability assessment. Am J Med Qual 1998;13:63-9.
37. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol 1989;42:937-45.
38. Mitchell JB, Ballard DJ, Matchar DB,. Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. Health Serv Res 2000;34:1413-28.
39. Long JA, Chang VW, Ibrahim SA, et al. Update on the health disparities literature. Ann Intern Med 2004;141:805-12.
40. Ibrahim SA, Siminoff LA, Burant CJ, et al. Understanding ethnic differences in the utilization of joint replacement for osteoarthritis: the role of patient-level factors. Med Care. 2002;40(1 Suppl):I44-51
41. Ibrahim SA, Siminoff LA, Burant CJ, et al. Differences in expectations of outcome mediate African American/white patient differences in "willingness" to consider joint replacement. Arthritis Rheum 2002;46:2429-35.
42. Margolis ML, Christie JD, Silvestri GA, et al. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med 2003;139:558-63.
43. Bosworth HB, Stechuchak KM, Grambow SC, et al. Patient risk perceptions for carotid endarterectomy: which patients are strongly averse to surgery? J Vasc Surg 2004;40:86-91.
44. Wong MD, Asch SM, Andersen RM, et al. Racial and ethnic differences in patients' preferences for initial care by specialists. Am J Med 2004;116:613-20.